Several R&D Activities Coupled with Innovation, Heating the Global Influenza Virus Infection Market

The global influenza virus infection market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period (2022-2028). Increased awareness of the impact of influenza on human health, and the corresponding increase in R&D activities for the launch of novel medications, are two of the key factors for the market growth. Due to the seriousness and possible risk of influenza, various governmental and non-governmental organizations have launched influenza awareness campaigns. As a result of these endeavors, there is a higher awareness of the need for new treatment alternatives. 

Browse the full report description “Global Influenza Virus Infection Market Size, Share & Trends Analysis Report By Treatment (Baloxavir Marboxil and Oseltamivir Phosphate), By Influenza Type (Influenza A and Influenza B) and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/influenza-virus-infection-market 

Additionally, major agencies such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), have sponsored and continue to undertake flu awareness programs. With a robust pipeline of vaccines, prominent market companies, and significant government support, therapeutically effective vaccinations have become more accessible. For instance, in May 2021, Seqirus, which is developing a cell-based quadrivalent seasonal influenza vaccine for children aged six months to four years, announced positive phase-Ill clinical data results. On the other hand, the impact of strict regulatory requirements combined with a lengthier time frame for conducting clinical trials is expected to hamper product development. 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Treatment
• By Influenza Type
• By Distribution Channel

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Genentech, Inc., Shionogi & Co., Ltd., Seqirus, Biocryst Pharmaceutical, Inc., GlaxoSmithKline plc., and others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Influenza Virus Infection Market Report Segment

By Treatment

• Baloxavir Marboxil
• Oseltamivir Phosphate

By Influenza Type

• Influenza A
• Influenza B

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Influenza Virus Infection Market Report Segment by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa